Calyxha Biotechnologies GmbH is developing novel therapies targeting #neurodegeneration, the underlying cause of major human diseases, such as Parkinson’s disease.
Calyxha Biotechnologies GmbH is developing novel therapies targeting #neurodegeneration, the underlying cause of major human diseases, such as Parkinson’s disease.